» Articles » PMID: 6602947

Multiple Tumour-specific Antigens Expressed on a Single Tumour Cell

Overview
Journal Nature
Specialty Science
Date 1983 Jul 14
PMID 6602947
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Tumours induced by physical or chemical carcinogens often express tumour-specific antigens that can induce strong protective immune defence in the host. The diversity of these unique antigens among different tumours is seemingly endless, and has been compared to that of immune receptors. At present, the nature and complexity of this antigenicity is not known for any single tumour. Here we describe the unique antigenicity expressed by a murine ultraviolet light (UV)-induced fibrosarcoma. This tumour is clearly subject to immune surveillance by the normal host, and does not grow progressively unless it undergoes antigenic changes. Using defined monoclonal T-cell probes and tumour variants selected in vitro with these probes, we found that the total antigenicity consisted of multiple independent components, all of which were tumour-specific and expressed simultaneously on the same tumour cell. The demonstration of this antigenic complexity will enable us to identify and compare the molecular composition of the components of this antigen, as well as to determine their individual roles in tumour rejection and escape.

Citing Articles

One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication.

Wolf S, Anastasopoulou V, Drousch K, Diehl M, Engels B, Yew P Clin Cancer Res. 2024; 30(8):1642-1654.

PMID: 38190111 PMC: 11018470. DOI: 10.1158/1078-0432.CCR-23-2905.


Genetically Engineered Mouse Models Support a Major Role of Immune Checkpoint-Dependent Immunosurveillance Escape in B-Cell Lymphomas.

Lemasson Q, Akil H, Feuillard J, Vincent-Fabert C Front Immunol. 2021; 12:669964.

PMID: 34113345 PMC: 8186831. DOI: 10.3389/fimmu.2021.669964.


Trends and advances in tumor immunology and lung cancer immunotherapy.

Aldarouish M, Wang C J Exp Clin Cancer Res. 2016; 35(1):157.

PMID: 27686848 PMC: 5043622. DOI: 10.1186/s13046-016-0439-3.


Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.

Leisegang M, Engels B, Schreiber K, Yew P, Kiyotani K, Idel C Clin Cancer Res. 2015; 22(11):2734-43.

PMID: 26667491 PMC: 4891260. DOI: 10.1158/1078-0432.CCR-15-2361.


Targeting cancer-specific mutations by T cell receptor gene therapy.

Blankenstein T, Leisegang M, Uckert W, Schreiber H Curr Opin Immunol. 2015; 33:112-9.

PMID: 25728991 PMC: 4557613. DOI: 10.1016/j.coi.2015.02.005.